Sasoter, Jian Jay Jofel C.
HRN: 15-53-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
OXACILLIN 500MG (VIAL)
05/18/2024
05/25/2024
IV
500 Mg
Q 6 Hours
Atopic Dermatitis With Secondary Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes